Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb 12;105(6):2040-5.
doi: 10.1073/pnas.0711619105. Epub 2008 Jan 31.

Structure and specificity of lamprey monoclonal antibodies

Affiliations

Structure and specificity of lamprey monoclonal antibodies

Brantley R Herrin et al. Proc Natl Acad Sci U S A. .

Abstract

Adaptive immunity in jawless vertebrates (lamprey and hagfish) is mediated by lymphocytes that undergo combinatorial assembly of leucine-rich repeat (LRR) gene segments to create a diverse repertoire of variable lymphocyte receptor (VLR) genes. Immunization with particulate antigens induces VLR-B-bearing lymphocytes to secrete antigen-specific VLR-B antibodies. Here, we describe the production of recombinant VLR-B antibodies specific for BclA, a major coat protein of Bacillus anthracis spores. The recombinant VLR-B antibodies possess 8-10 uniform subunits that collectively bind antigen with high avidity. Sequence analysis, mutagenesis, and modeling studies show that antigen binding involves residues in the beta-sheets lining the VLR-B concave surface. EM visualization reveals tetrameric and pentameric molecules having a central core and highly flexible pairs of stalk-region "arms" with antigen-binding "hands." Remarkable antigen-binding specificity, avidity, and stability predict that these unusual LRR-based monoclonal antibodies will find many biomedical uses.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Production of monoclonal VLR-B antibodies specific for BclA-CTD of B. anthracis. (A) VLR-B antibody clones expressed by HEK-293T cells detect recombinant BclA-CTD by ELISA. NT indicates supernatant from nontransfected cells. (B and C) VLR-B antibody clones specifically detect B. anthracis spores by ELISA (B) and flow cytometry (C). ΔBclA, BclA-deficient B. anthracis spores.
Fig. 2.
Fig. 2.
A model of the putative antigen binding surface of a BclA-CTD-specific VLR-B antibody. (A) Homology-based model of the tertiary structure of clone VLR4 constructed by using the crystal structure coordinates of hagfish VLR-B (PDB ID codes 2O6R and 2O6S) as a template. (Upper) Frontal view. (Lower) Side view. Hypervariable positions of each LRR module are indicated by color: LRR-NT (blue), LRR1 (light blue), LRRV (green), LRRVe (light green), CP (yellow), and LRR-CT (orange). (B) Alignment of the LRR-CT sequences of VLR-B clones specific for BclA-CTD. Invariant residues are shaded black, and variable residues are shaded orange.
Fig. 3.
Fig. 3.
Quaternary structure of secreted VLR-B antibodies. (A) Molecular mass estimate of a purified recombinant VLR-B antibody (VLR4) by Ferguson plot analysis. Blue dots, Molecular mass standards; red line, VLR4. (B) Western blot of a partially reduced VLR-B antibody; monomeric (*) and dimeric (**) subunits of the partially reduced antibody. (C) Negative stain TEM of VLR4. (Upper) Pentameric arrangement of VLR-B subunits. (Lower) Flexibility of subunits. (D) A model of VLR-B antibody quaternary structure with red lines representing disulfide bonds. (E) MS/MS sequencing of tryptic fragments of reduced VLR4. Ions matching the sequence of the C terminus of VLR4 are labeled in the spectrograph. CAM indicates carboxyamidomethylation of cysteine by iodoacetamide. (F) Cartoon depicting the location of the cysteine-rich peptide in the VLR-B antibody. The predicted GPI cleave site (bold text) is indicated by an arrow, cysteines that may form intermolecular disulfide bonds are highlighted red, and the peptide detected in E is indicated by a line above the text.
Fig. 4.
Fig. 4.
The primary antigen binding site of VLR-B is located on the concave surface. (A) Sequence alignment of high-avidity (Ba41, Ba191, VLR4) and low-avidity (VLR5) VLR-B antibodies specific for BclA-CTD. Hypervariable positions are shaded black. Amino acids in VLR5 that differ from the high-avidity clones are shaded in color if they are in hypervariable positions or gray if located elsewhere, except V97/N98 (yellow). (B) Homology-based model of VLR5 structure. Amino acids in hypervariable positions are color-coded as in A. (C) Surface plasmon resonance measurement of the interaction between VLR4WT, VLR5WT, or VLR5 mutant antibodies with BclA-CTD. VLR5 residues in hypervariable positions that differ from the high-avidity clones were mutated to the consensus amino acid of the high-avidity clones at that position. Response curves are color-coded with respect to amino acid positions depicted in A and B.

References

    1. Pancer Z, et al. Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature. 2004;430:174–180. - PubMed
    1. Pancer Z, et al. Variable lymphocyte receptors in hagfish. Proc Natl Acad Sci USA. 2005;102:9224–9229. - PMC - PubMed
    1. Rogozin IB, et al. Evolution and diversification of lamprey antigen receptors: evidence for involvement of an AID-APOBEC family cytosine deaminase. Nat Immunol. 2007;8:647–656. - PubMed
    1. Alder MN, et al. Diversity and function of adaptive immune receptors in a jawless vertebrate. Science. 2005;310:1970–1973. - PubMed
    1. Nagawa F, et al. Antigen-receptor genes of the agnathan lamprey are assembled by a process involving copy choice. Nat Immunol. 2007;8:206–213. - PubMed

Publication types

LinkOut - more resources